All stories by Sohini Das, Aneeka Chatterjee
'Real growth and opportunity are going to come from GLP-1'
Rediff.com21 Aug 2024'It is not just the US and European opportunity, but it is a huge global opportunity.'
'The formulations business been a growth driver'
Rediff.com24 Feb 2024'However, we have seen weakness in our active pharmaceutical ingredients business.'
© 2024 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Feedback - About us - Terms of use - Grievances